BioProtect

company

About

BioProtect is an international medical device startup engaged in developing biodegradable balloon spacers for radiation therapy.

  • 11 - 50

Details

Last Funding Type
Series D
Last Funding Money Raised
$25M
Industries
Health Care,Medical Device
Founded date
Jan 1, 2004
Number Of Employee
11 - 50
Operating Status
Active

BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25M
BioProtect has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on Sep 21, 2020 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 21, 2020 Series D $25M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
BioProtect is funded by 2 investors. Medtronic and Triventures are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series D
Triventures Series D